| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |